Sexual behavior, human papillomavirus type 16 (HPV 16) infection, and HPV 16 seropositivity

Sexually Transmitted Diseases

Volumn 29, Issue 3, 2002, Pages 182-187

  Castle, Philip E ^a   Shields, Tammy ^a   Kirnbauer, Reinhard ^b   Manos, M Michele ^c   Burk, Robert D ^d   Glass, Andrew G ^c   Scott, David R ^e   Sherman, Mark E ^a   Schiffman, Mark ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Universitatsklinik fur Dermatologie   (Austria)

^c DIVISION OF RESEARCH   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CYTODIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OPTICAL DENSITY; POLYMERASE CHAIN REACTION; QUESTIONNAIRE; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; UNITED STATES; VIRUS INFECTION; WART VIRUS;

EID: 0036123531     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200203000-00009     Document Type: Article

References (22)

1. Prevalence of HPV DNA in cervical cancer: A worldwide perspective
2. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
3. Human papillomavirus and cancer: The epidemiological evidence
4. Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia
5. Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesions
6. Serum antibodies to human papillomavirus 16 proteins in women from Brazil with invasive cervical carcinoma
7. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16
8. Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and -negative women
9. Seropositivity against HPV 16 capsids: A better marker of past sexual behaviour than presence of HPV DNA
10. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia
11. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions
12. Determination of genital human papillomavirus infection by consensus PCR amplification
13. Persistence of type-specific human papillomavirus infection among cytologically normal women
14. An analysis of transformations
15. Wilcoxon-type test for trend
16. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica
17. Immunological analyses of human papillomavirus capsids
18. Mucosal immune system of the human genital tract
19. Cytokine and immunoglobulin concentrations in cervical secretions: Reproducibility of the Weck-cel collection instrument and correlates of immune measures
20. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection
21. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma
22. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine